ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Nanomedicine and Nanoparticle Drug Delivery

Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoscale materials, such as nanoparticles, to diagnose, treat, and prevent diseases. The key advantage of nanomedicine lies in its ability to interact with biological systems at the molecular level, leading to more precise and effective treatments.

Nanoparticle drug delivery is a specific application within nanomedicine. It involves using nanoparticles-tiny particles typically ranging from 1 to 100 nanometers in size-to deliver drugs directly to targeted cells or tissues. This targeted approach can enhance the efficacy of drugs while minimizing side effects. Nanoparticles can be engineered to control the release of the drug over time, protect the drug from degradation, and improve its solubility and bioavailability. Common types of nanoparticles used include liposomes, polymeric nanoparticles, and dendrimers. Nanoparticle drug delivery is a promising field that holds the potential to revolutionize the way diseases are treated, particularly in areas like cancer therapy, where targeted drug delivery is crucial for success.

Nanomedicine and Nanoparticle Drug Delivery

Expert PPTs

Speaker PPTs

Conference Proceedings